Some people with psoriatic arthritis (PsA) may have a disease that is difficult to manage (D2M) or does not respond to ...

Some people with psoriatic arthritis (PsA) may have disease that is difficult to manage (D2M) or does not respond to ...

In this Healio video exclusive, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, highlights a pair of “timely and cool” stories on point-of-care AI use and the FDA approval of ...

Results of a systematic review and meta-analysis showed that LDN was safe and effective for reducing pain and improving ...

Upadacitinib treatment was associated with reduced non-nociceptive pain among patients with axSpA, including both neuropathic ...

Tonix Pharmaceuticals (TNXP) presented data on Tonmya, which was investigated as TNX-102 SL, at the 2025 American College of Rheumatology ...

Tonmya demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT studyTreatment ...

DOCTORS have dubbed her the “Ozempic poster girl” after she managed to keep her six stone weight loss off for two YEARS after ...

The latest figures from the DWP show there are now nearly 1.2 million adults across the UK receiving support through PIP for ...

The Department for Work and Pensions (DWP) has unveiled its latest figures, showing that nearly 1.2 million adults across ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated, commercial biotechnology company, announced today that a poster on Tonmya™ (cyclobenzaprine HCl ...

People who develop rheumatoid arthritis experience changes to their immune systems long before their joints become swollen and painful, suggesting that early treatment might stop or limit damage, a ...